Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

You can use it to treat conditions such as stubborn dandruff and psoriasis. Shampoos containing ketoconazole are available both over the counter (OTC) and by prescription from your doctor.

Skyrise sees red. Photo Courtesy of Skyrise. Skyrise is set to wow the audience with their upcoming performance “Hounds of Death” at Clarke Recital Hall on April 16 at 7:30p.m, promising an innovative ...

Compared with patients without psoriasis, pregnant patients with psoriasis are at higher risk for cardiovascular complications during delivery. Pregnant patients with psoriasis are at higher risk for ...

Icotrokinra had more significant improvements than placebo for multiple skin clearance measures following 16 weeks of treatment for plaque psoriasis in adolescents and adults. Icotrokinra is ...

EC president Ursula von der Leyen is scheduled to hold a call with the European pharmaceuticals industry. Credit: VYACHESLAV OSELEDKO via Getty Images. European Commission (EC) President Ursula von ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. The singer, one half of the folk-rock duo Simon & Garfunkel, has teamed with Sun Pharma to discuss how ...

If a person has moderate or severe psoriasis and a doctor believes drug therapy is medically necessary, Medicare can generally help cover the cost. Possible covered medications include ...

Obesity was linked to reduced long-term effectiveness of biologic therapy in patients with severe plaque psoriasis in a study, with dysregulated innate immune responses contributing to treatment ...

In your practice, what are the rates of persistence and adherence to plaque psoriasis treatment, and what key factors influence these outcomes?

The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) who have not responded to conventional systemic therapies. This ...